Erin Wansbrough, Chief Executive, Soda Inc
Erin Wansbrough is an accomplished Chief Executive and governance professional celebrated for her significant contributions to New Zealand's technology sector, particularly in healthcare and med tech. With a robust commercial background in strategy development and a blend of technical and commercialisation expertise, Erin excels in product market fit development, the strategic execution of go-to-market plans, and capital raising, including securing non-diluting funding.
Her track record demonstrates effective governance, marked by her service on various Boards. Presently, Erin holds the Chair positions for Hospice West Auckland and the Cultivate Trust. Additionally, she leads as the Chief Executive of SODA Inc Ltd, a prominent business incubator. Throughout her illustrious career, Erin has occupied leadership roles in renowned organisations such as GlaxoSmithKline, AstraZeneca, Life Technologies, Callaghan Innovation, MBIE, and Adherium NZ Ltd, underscoring her real world experience in bringing advanced technologies to market across various healthcare and biotech industries.